Accuray Inc - Understand $aray stock

$ARAY Market Cap: $217.3 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$446.6M

TTM

Gross Margin

32.22%

TTM

Net Earnings

-$15.55M

TTM

Current Assets

$323.2M

Q2 2024

Current Liabilities

$195.3M

Q2 2024

Current Ratio

165.54%

Q2 2024

Total Assets

$468.6M

Q2 2024

Total Liabilities

$423.5M

Q2 2024

Book Value

$45.08M

Q2 2024

Cash

$68.57M

Q2 2024

P/E

-13.98

Sep 13, 2024 EST

Free Cash Flow

-$24.93M

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue	$446.6M	$447.6M	$429.9M	$396.3M	$382.9M	$418.8M	$404.9M	$383.4M	$398.8M	$379.8M	$195.8M	$316.0M	$409.2M	$222.3M	$221.6M	$233.6M	$210.4M	$140.5M	$52.90M	$22.40M	$19.60M
YoY Change	-0.24%	4.12%	8.48%	3.49%	-8.56%	3.43%	5.6%	-3.86%	5.0%	93.96%	-38.03%	-22.79%	84.1%	0.31%	-5.14%	11.03%	49.75%	165.6%	136.16%	14.29%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Revenue	$446.6M	$447.6M	$429.9M	$396.3M	$382.9M	$418.8M	$404.9M	$383.4M	$398.8M	$379.8M	$195.8M	$316.0M	$409.2M	$222.3M	$221.6M	$233.6M	$210.4M	$140.5M	$52.90M	$22.40M	$19.60M
Cost Of Revenue	$303.6M	$293.6M	$270.0M	$236.8M	$233.2M	$256.1M	$243.2M	$242.1M	$240.1M	$234.4M	$226.6M	$218.3M	$272.0M	$115.0M	$117.6M	$118.3M	$103.4M	$60.40M	$27.50M	$11.10M	$8.500M
Gross Profit	$142.9M	$154.0M	$160.0M	$159.5M	$149.7M	$162.7M	$161.7M	$141.3M	$158.7M	$145.4M	$142.8M	$97.64M	$137.3M	$107.2M	$104.0M	$115.3M	$107.0M	$80.00M	$25.40M	$11.30M	$11.10M
Gross Profit Margin	32.01%	34.4%	37.21%	40.25%	39.1%	38.84%	39.93%	36.86%	39.8%	38.28%	72.93%	30.9%	33.54%	48.25%	46.93%	49.36%	50.86%	56.94%	48.02%	50.45%	56.63%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Selling, General & Admin	$92.69M	$94.45M	$94.06M	$84.54M	$87.40M	$105.6M	$108.2M	$101.2M	$106.9M	$108.8M	$107.2M	$112.1M	$112.2M	$93.77M	$69.70M	$81.70M	$75.00M	$61.80M	$41.10M	$24.50M	$15.30M
YoY Change	-1.87%	0.42%	11.25%	-3.27%	-17.22%	-2.46%	6.91%	-5.32%	-1.72%	1.47%	-4.35%	-0.11%	19.67%	34.53%	-14.69%	8.93%	21.36%	50.36%	67.76%	60.13%
% of Gross Profit	64.85%	61.35%	58.8%	53.0%	58.37%	64.91%	66.94%	71.63%	67.38%	74.83%	75.08%	114.81%	81.75%	87.44%	67.02%	70.86%	70.09%	77.25%	161.81%	216.81%	137.84%
Research & Development	$49.73M	$57.13M	$57.75M	$52.73M	$49.78M	$56.49M	$57.25M	$49.92M	$56.65M	$55.80M	$53.72M	$66.20M	$81.29M	$41.30M	$31.50M	$36.00M	$32.90M	$26.80M	$17.80M	$11.70M	$7.300M
YoY Change	-12.95%	-1.08%	9.53%	5.92%	-11.88%	-1.32%	14.68%	-11.88%	1.53%	3.86%	-18.84%	-18.56%	96.82%	31.11%	-12.5%	9.42%	22.76%	50.56%	52.14%	60.27%
% of Gross Profit	34.8%	37.11%	36.11%	33.06%	33.25%	34.73%	35.41%	35.32%	35.69%	38.38%	37.62%	67.8%	59.22%	38.51%	30.29%	31.22%	30.75%	33.5%	70.08%	103.54%	65.77%
Depreciation & Amortization		$4.527M	$5.513M	$6.389M	$7.541M	$10.49M	$9.732M	$18.04M	$18.30M	$19.49M	$20.56M	$25.56M	$32.59M	$7.566M	$7.120M	$6.650M	$7.690M	$6.250M	$3.810M	$2.080M	$1.450M
YoY Change		-17.88%	-13.71%	-15.28%	-28.12%	7.8%	-46.06%	-1.38%	-6.13%	-5.22%	-19.56%	-21.56%	330.77%	6.26%	7.07%	-13.52%	23.04%	64.04%	83.17%	43.45%
% of Gross Profit		2.94%	3.45%	4.01%	5.04%	6.45%	6.02%	12.77%	11.53%	13.4%	14.4%	26.18%	23.74%	7.06%	6.85%	5.77%	7.19%	7.81%	15.0%	18.41%	13.06%
Operating Expenses	$142.4M	$151.6M	$151.8M	$137.3M	$137.2M	$162.1M	$165.5M	$151.2M	$163.6M	$164.6M	$160.9M	$178.3M	$193.5M	$135.1M	$101.2M	$117.7M	$107.9M	$88.60M	$58.90M	$36.20M	$22.60M
YoY Change	-6.04%	-0.15%	10.59%	0.07%	-15.36%	-2.07%	9.48%	-7.59%	-0.62%	2.27%	-9.73%	-7.86%	43.26%	33.47%	-14.02%	9.08%	21.78%	50.42%	62.71%	60.18%
Operating Profit	$504.0K	$2.382M	$8.148M	$22.24M	$12.54M	$583.0K	-$3.797M	-$9.823M	-$4.873M	-$19.20M	-$18.14M	-$80.66M	-$56.23M	-$27.83M	$2.800M	-$2.400M	-$900.0K	-$8.600M	-$33.50M	-$24.90M	-$11.50M
YoY Change	-78.84%	-70.77%	-63.36%	77.33%	2050.77%	-115.35%	-61.35%	101.58%	-74.62%	5.82%	-77.5%	43.43%	102.07%	-1093.89%	-216.67%	166.67%	-89.53%	-74.33%	34.54%	116.52%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Interest Expense	$1.838M	$2.572M	$8.129M	$16.89M	$18.08M	$15.08M	$14.96M	-$18.60M	-$18.30M	-$18.60M	-$14.20M	-$12.90M	-$11.80M	$2.200M	$400.0K	$3.800M	$7.400M	$3.500M	$100.0K	-$200.0K	-$100.0K
YoY Change	-28.54%	-68.36%	-51.88%	-6.57%	19.86%	0.84%	-180.42%	1.64%	-1.61%	30.99%	10.08%	9.32%	-636.36%	450.0%	-89.47%	-48.65%	111.43%	3400.0%	-150.0%	100.0%
% of Operating Profit	364.68%	107.98%	99.77%	75.97%	144.19%	2587.31%									14.29%
Other Income/Expense, Net	-$14.16M	-$11.74M	-$10.39M	-$27.67M	-$6.700M	-$14.93M	-$19.22M	-$18.72M	-$18.30M		-$14.22M	-$13.13M	-$12.52M	$2.288M	-$300.0K	-$400.0K
YoY Change	20.61%	13.0%	-62.44%	312.93%	-55.11%	-22.35%	2.7%	2.31%			8.25%	4.89%	-647.25%	-862.67%	-25.0%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004
Pretax Income	-$11.82M	-$6.788M	-$2.002M	-$4.559M	$5.690M	-$14.34M	-$23.02M	-$28.54M	-$32.71M	-$37.80M	-$42.49M	-$104.0M	-$75.39M	-$28.17M	$2.800M	$700.0K	$6.300M	-$5.000M	-$33.40M	-$25.10M	-$11.70M
YoY Change	74.13%	239.06%	-56.09%	-180.12%	-139.67%	-37.69%	-19.34%	-12.75%	-13.47%	-11.03%	-59.13%	37.9%	167.66%	-1105.96%	300.0%	-88.89%	-226.0%	-85.03%	33.07%	114.53%
Income Tax	$3.725M	$2.492M	$3.345M	$1.752M	$1.863M	$2.086M	$878.0K	$1.038M	$2.300M	$2.400M	$3.088M	$3.573M	$2.595M	$1.116M	$0.00	$100.0K	$900.0K	$1.400M	$300.0K	$100.0K	$0.00
% Of Pretax Income					32.74%										0.0%	14.29%	14.29%
Net Earnings	-$15.55M	-$9.280M	-$5.347M	-$6.311M	$3.827M	-$16.43M	-$23.90M	-$29.58M	-$25.50M	-$40.20M	-$35.40M	-$116.5M	-$78.45M	-$27.11M	$2.800M	$600.0K	$5.400M	-$5.600M	-$33.70M	-$25.20M	-$11.70M
YoY Change	67.51%	73.56%	-15.27%	-264.91%	-123.29%	-31.25%	-19.2%	16.0%	-36.57%	13.56%	-69.62%	48.51%	189.38%	-1068.25%	366.67%	-88.89%	-196.43%	-83.38%	33.73%	115.38%
Net Earnings / Revenue	-3.48%	-2.07%	-1.24%	-1.59%	1.0%	-3.92%	-5.9%	-7.71%	-6.39%	-10.58%	-18.08%	-36.87%	-19.17%	-12.2%	1.26%	0.26%	2.57%	-3.99%	-63.71%	-112.5%	-59.69%
Basic Earnings Per Share		-$0.10	-$0.06	-$0.07	$0.04
Diluted Earnings Per Share	-$0.16	-$0.10	-$0.06	-$0.07	$0.04	-$0.19	-$281.5K	-$358.8K	-$316.8K	-$513.4K	-$467.0K	-$1.408M	-$1.016M	-$444.3K	$46.51K	$10.22K	$89.40K	-$181.8K	-$2.106M	-$1.762M	-$1.000M

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005
Cash & Short-Term Investments	$68.57M	$89.40M	$88.74M	$116.4M	$107.6M	$76.80M	$83.10M	$96.00M	$167.0M	$143.9M	$171.9M	$174.4M	$143.5M	$95.90M	$145.3M	$101.5M	$122.5M	$204.8M	$27.90M	$17.00M
YoY Change	-23.3%	0.75%	-23.75%	8.15%	40.1%	-7.58%	-13.44%	-42.51%	16.05%	-16.29%	-1.43%	21.53%	49.64%	-34.0%	43.15%	-17.14%	-40.19%	634.05%	64.12%
Cash & Equivalents	$68.57M	$89.40M	$88.74M	$116.4M	$107.6M	$76.80M	$83.10M	$1.600M	$13.40M	$79.60M	$92.30M	$73.30M	$143.5M	$95.90M	$45.40M	$36.80M	$36.90M	$204.8M	$27.90M	$17.00M
Short-Term Investments							$0.00	$23.90M	$57.70M	$64.30M	$79.60M	$101.1M			$99.90M	$64.60M	$85.50M	$0.00
Other Short-Term Assets	$24.34M	$28.70M	$25.46M	$25.12M	$24.90M	$34.60M	$26.60M	$35.20M	$21.90M	$26.60M	$32.70M	$24.50M	$23.20M	$30.10M	$27.30M	$25.70M	$42.90M	$38.60M	$8.300M	$5.200M
YoY Change	-15.2%	12.75%	1.36%	0.86%	-28.03%	30.08%	-24.43%	60.73%	-17.67%	-18.65%	33.47%	5.6%	-22.92%	10.26%	6.23%	-40.09%	11.14%	365.06%	59.62%
Inventory	$138.3M	$145.2M	$142.3M	$125.9M	$134.4M	$120.8M	$108.5M	$105.1M	$116.0M	$106.2M	$87.80M	$81.60M	$81.70M	$97.80M	$28.20M	$28.90M	$23.00M	$17.00M	$10.10M	$6.400M
Prepaid Expenses
Receivables	$92.00M	$74.78M	$94.44M	$85.36M	$90.60M	$111.9M	$66.00M	$72.80M	$56.80M	$77.70M	$72.20M	$55.50M	$67.90M	$61.90M	$38.00M	$36.40M	$33.90M	$10.10M	$11.70M	$5.100M
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$323.2M	$338.0M	$350.9M	$352.8M	$357.5M	$344.1M	$284.2M	$309.0M	$361.7M	$354.3M	$364.5M	$335.9M	$316.3M	$285.7M	$238.7M	$192.5M	$222.4M	$270.6M	$58.00M	$33.70M
YoY Change	-4.38%	-3.66%	-0.53%	-1.32%	3.89%	21.08%	-8.03%	-14.57%	2.09%	-2.8%	8.51%	6.2%	10.71%	19.69%	24.0%	-13.44%	-17.81%	366.55%	72.11%
Property, Plant & Equipment	$58.55M	$46.78M	$29.48M	$34.85M	$44.00M	$17.10M	$23.70M	$23.10M	$27.90M	$31.80M	$34.40M	$34.70M	$37.50M	$44.80M	$14.70M	$15.10M	$17.10M	$23.90M	$21.90M	$13.00M
YoY Change	25.16%	58.66%	-15.41%	-20.79%	157.31%	-27.85%	2.6%	-17.2%	-12.26%	-7.56%	-0.86%	-7.47%	-16.29%	204.76%	-2.65%	-11.7%	-28.45%	9.13%	68.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$9.826M	$15.13M	$13.88M	$15.94M	$13.90M											$57.30M	$37.00M	$0.00
YoY Change	-35.05%	9.0%	-12.9%	14.64%												54.86%
Other Assets	$19.29M	$21.38M	$15.21M	$18.14M	$9.000M	$14.20M	$5.300M	$8.200M	$6.400M	$7.000M	$14.70M	$14.00M	$10.40M	$4.700M	$4.900M	$4.400M	$13.10M	$31.90M	$52.80M	$34.00M
YoY Change	-9.8%	40.62%	-16.18%	101.57%	-36.62%	167.92%	-35.37%	28.12%	-8.57%	-52.38%	5.0%	34.62%	121.28%	-4.08%	11.36%	-66.41%	-58.93%	-39.58%	55.29%
Total Long-Term Assets	$145.4M	$141.2M	$122.0M	$127.3M	$133.4M	$94.10M	$94.50M	$97.50M	$107.3M	$112.5M	$130.7M	$140.0M	$156.9M	$170.1M	$24.50M	$81.90M	$72.60M	$61.50M	$80.60M	$53.20M
YoY Change	2.98%	15.76%	-4.21%	-4.55%	41.76%	-0.42%	-3.08%	-9.13%	-4.62%	-13.93%	-6.64%	-10.77%	-7.76%	594.29%	-70.09%	12.81%	18.05%	-23.7%	51.5%
Total Assets	$468.6M	$479.2M	$472.8M	$480.1M	$490.9M	$438.2M	$378.7M	$406.5M	$469.0M	$466.8M	$495.2M	$475.9M	$473.2M	$455.8M	$263.2M	$274.4M	$295.0M	$332.1M	$138.6M	$86.90M
YoY Change
Accounts Payable	$50.02M	$33.74M	$31.34M	$19.47M	$23.10M	$29.60M	$19.70M	$17.50M	$15.20M	$13.10M	$15.60M	$15.90M	$18.20M	$38.60M	$10.30M	$14.90M	$13.00M	$14.10M	$4.700M	$5.400M
YoY Change	48.26%	7.67%	60.97%	-15.73%	-21.96%	50.25%	12.57%	15.13%	16.03%	-16.03%	-1.89%	-12.64%	-52.85%	274.76%	-30.87%	14.62%	-7.8%	200.0%	-12.96%
Accrued Expenses	$51.85M	$66.22M	$68.29M	$62.51M	$53.40M	$63.90M	$51.40M	$49.30M	$40.90M	$40.70M	$57.00M	$35.40M	$54.70M	$70.40M	$21.50M	$16.20M	$11.90M	$17.20M	$15.10M	$5.600M
YoY Change	-21.69%	-3.04%	9.26%	17.05%	-16.43%	24.32%	4.26%	20.54%	0.49%	-28.6%	61.02%	-35.28%	-22.3%	227.44%	32.72%	36.13%	-30.81%	13.91%	169.64%
Deferred Revenue
YoY Change
Short-Term Debt		$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$2.900M
YoY Change																			-100.0%
Long-Term Debt Due	$7.756M	$5.721M	$8.563M	$3.790M			$0.00	$113.0M	$39.90M
YoY Change	35.57%	-33.19%	125.94%				-100.0%	183.21%
Total Short-Term Liabilities	$195.3M	$198.6M	$208.9M	$192.4M	$182.3M	$192.2M	$169.4M	$284.5M	$210.2M	$169.9M	$184.6M	$155.9M	$174.2M	$203.0M	$86.70M	$112.4M	$134.6M	$122.0M	$61.80M	$31.50M
YoY Change	-1.7%	-4.89%	8.58%	5.52%	-5.15%	13.46%	-40.46%	35.35%	23.72%	-7.96%	18.41%	-10.51%	-14.19%	134.14%	-22.86%	-16.49%	10.33%	97.41%	96.19%
Long-Term Debt	$164.4M	$171.6M	$171.9M	$170.0M	$189.3M	$159.8M	$131.1M	$51.50M	$170.5M	$199.7M	$195.6M	$198.8M	$79.50M	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change	-4.17%	-0.2%	1.12%	-10.19%	18.46%	21.89%	154.56%	-69.79%	-14.62%	2.1%	-1.61%	150.06%
Other Long-Term Liabilities	$63.88M	$55.36M	$38.90M	$48.89M	$55.70M	$36.30M	$29.60M	$23.90M	$28.60M	$21.40M	$16.50M	$14.50M	$15.70M	$12.40M	$6.400M	$8.100M	$29.60M	$84.60M	$130.2M	$84.00M
YoY Change	15.39%	42.32%	-20.45%	-12.22%	53.44%	22.64%	23.85%	-16.43%	33.64%	29.7%	13.79%	-7.64%	26.61%	93.75%	-20.99%	-72.64%	-65.01%	-35.02%	55.0%
Total Long-Term Liabilities	$228.3M	$226.9M	$210.8M	$218.9M	$245.0M	$196.1M	$160.7M	$75.40M	$199.1M	$221.1M	$212.1M	$213.3M	$95.20M	$12.40M	$6.400M	$8.100M	$29.60M	$84.60M	$130.2M	$84.00M
YoY Change	0.6%	7.65%	-3.7%	-10.65%	24.94%	22.03%	113.13%	-62.13%	-9.95%	4.24%	-0.56%	124.05%	667.74%	93.75%	-20.99%	-72.64%	-65.01%	-35.02%	55.0%
Total Liabilities	$423.5M	$425.6M	$419.7M	$411.3M	$427.3M	$388.3M	$330.1M	$359.9M	$409.4M	$391.0M	$396.6M	$369.1M	$277.5M	$226.0M	$93.10M	$120.5M	$164.2M	$206.7M	$192.0M	$115.5M
YoY Change	-0.47%	1.4%	2.04%	-3.75%	10.04%	17.63%	-8.28%	-12.09%	4.71%	-1.41%	7.45%	33.01%	22.79%	142.75%	-22.74%	-26.61%	-20.56%	7.66%	66.23%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2023	2022	2021	2020	2019	2018	2013	2012	2011
Basic Shares Outstanding	94.88M	92.10M	92.03M	89.87M	87.47M	84.89M	73.28M shares	70.89M shares	60.09M shares
Diluted Shares Outstanding	94.88M	92.10M	92.03M	90.62M	87.47M	84.89M	73.28M shares	70.89M shares	60.09M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Dividends

Stock Price

Market Cap: $217.34 Million

About Accuray Inc

Accuray, Inc. is a radiation oncology company, which engages in the development, manufacture, and sale of treatment solutions that include CyberKnife and Tomo Therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. The company is headquartered in Madison, Wisconsin and currently employs 1,024 full-time employees. The company went IPO on 2007-02-08. The firm develops, manufactures, sells, and supports solutions that are designed to deliver radiation treatments. Its solutions are designed to advance patient care during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, the Company also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other professional services.

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories Accelerate Diagnostics Inc Apyx Medical Corp Apollo Endosurgery, Inc. CVRx Inc SeaSpine Holdings Corp Sensus Healthcare Inc Tactile Systems Technology Inc Zomedica Corp